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Table II. Double-Label IF Staining Results 
Monoclonal Neonatal Foreskin 
Antibodies Antigen Melanocytes 
BM-63 {32 micro globulin +++ (surt."1ce) on all cells 
L243 HLA-DR Negative 
TA99 (MEL-5) Mature melanosomes + + + (cytoplasmic) on 
>95% of cells 
WM-9 Human nerve growth + to + + + (surface) on 
factor receptor -20% of cells 
or nuclear antigens were used. To conclusively identifY differenti­
ated melanocytes in primary cultures of epidermal cells from the 
four donors, double-label IF stainings with the autologous serum 
and MEL-5, anti-nerve growth factor receptor or anti-major 
histocompatibility monoclonal antibodies were also performed 
(Table II). 
In the four cases studied, no cell-surface antibody binding from 
any of the donor's sera against viable autologous melanocytes was 
found, by either standard or complement-fixing IF. Moreover, 
neither these four sera nor any of 20 sera from patients with active 
AA was positive for cell-surface IF reactivity on viable neonatal 
foreskin melanocytes by standard IF staining. In contrast to the lack 
of cell-surface reactivity, nuclear and/or cytoplasmic binding on 
fixed and permeabilized cells was detected in some cases. 
To further confirm that the lack of cell-surface binding was not 
due to the particular selection of sera employed, we also tested a 
serum sample, kindly provided by Dr. J.-c. Bystryn, New York 
University, which had been previously found to produce comple-
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ment-mediated cytOtOXlClty on human melanocytes in culture 
a.-c. Bystryn, personal communication). Again, this serum did not 
show any detectable cell-surface binding on viable melanocytes 
cultured from all four donors or from neonatal foreskin, either in 
standard or complement-fixing IF stainings at 1:5 and 1:2 dilutions, 
respectively. 
These negative results argue against melanocytes being the 
target of autoimmunity in AA. Alternatively, they may be the 
result of 1) loss of autoantigen expression by cultured melano­
cytes, 2) antigenic differences between follicular and epidermal 
melanocytes, or 3) the autoimmune attack in AA being exclu­
sively mediated by T-cell (and not autoantibody-dependent) 
mechanisms. 
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T
he thymus gland is regarded as the prime develop­
mental organ educating thymocytes to distinguish 
"self" from "nonself," producing T lymphocytes and 
providing them with specific antigen-recognizing 
receptors. In addition to being a lymphocyte-differ­
entiatIng gland it is also an endocrine organ producing several 
hormones. Thymulin, a nonapeptide produced by the gland, is a 
hormone involved in T -lymphocyte differentiation that is released 
by pituitary factors. Although the pathogenesis of alopecia areata is 
unclear all evidence suggests an autoimmune etiology; there is also 
an increased incidence in Down's Syndrome, hypothymic or athymic. 
We studied 77 patients with alopecia areata (48 patchy disease, 
12 alopecia totalis, and 17 alopecia universalis) measuring early 
Reprint requests to: Dr. D.A. Fenton, StJolm's Dermatology Centre, St 
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morning plasma thymulin levels using a radioimmunoassay com­
paring 64 normal age- and sex-matched controls. 
The results demonstrated a significant decrease in plasma thymu­
lin levels in normal controls over 20 years of age, although older 
patients still had detectable levels with a mean thymulin of 371 
Fg/mL The alopecia areata patients as a group had low thymulin 
levels; 75% of patients with alopecia areata over 20 years of age had 
thymulin levels below the normal mean value. In patients with 
patchy alopecia areata over 20 years of age, 12 had undetectable 
levels, and the remainder a low mean plasma thymulin of 296 
Fg/rnl (p < 0.00001). Ninety percent of alopecia areata patients less 
than 20 years of age had plasma thymulin levels below the control 
mean (1080 Fg/rnl). There was no correlation between the pres­
ence of circulating organ-specific antibodies or atopic disease and 
thymulin levels. When the extent of disease was studied, mean 
levels were dearly lowered in patients with patchy alopecia areata, 
further depressed in alopecia totalis, and often undetectable in 
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Table I. Plasma Thymulin in Children Under 20 Years 
of Age 
Number Mean ± SEM Sign" 
Active regrowth 8 1014 ± 165 P < 0.06 
Static 5 680 ± 160 P < 0.01 
Active loss 5 439 ± 88 P < 0. 001 
Controls 31 1499 ± 119 
U Sign, difference between controls and disease category. 
alopecia universalis, i.e., the more extensive the disease the lower 
the plasma thymulin. 
Having demonstrated a positive correlation between reduced 
levels of thymic hormone and extent of alopecia we then 
investigated the relationship between plasma thymulin and 
disease activity in alopecia areata. We studied a further 96 patients 
with alopecia areata who were categorized into three groups: active 
hair loss, active hair regrowth, or "status quo" (neither hair loss nor 
hair growth). 
The results (Table I) showed that in patients less than 20 years 
of age, 50% of those with active hair regrowth had levels of plasma 
thymulin below the normal mean, 80% of patients in "status quo" 
had low levels but 100% of individuals with active hair loss were 
below the normal mean value (p < 0.001). When patients with 
active hair growth and active hair loss were compared, there was 
also a statistically significant diEerence between these two groups. 
In patients over 20 years of age (Table II) there was no significant 
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Table II. Plasma Thymulin in Adults Over 20 Years 
of Age 
Number ND Mean ± SEM Sign" 
Active regrowth 13 3 431 ± 44 NS 
Static 11 3 277 ± 28 P < 0.02 
Active loss 31 17 280 ± 17 P < 0.001 
Controls 48 2 371 ± 18 
<I Sign, difference between controls and disease category. ND, non-detectable values 
(lower assay limit 150 Fg/ml). NS, not significant. When the presence of non­
detectable values is also considered, all of the results for adults are even more 
significant than shown above because the percentage ofNDs in alopecia areata patients 
is higher than in controls. 
ditference between normal controls and recovering regrowing 
alopecia areata. In those with static disease, 78% of cases had values 
below the normal mean and in patients with active hairloss 81% 
were below the normal mean value (p < 0.001). 
In conclusion these results indicate that the greater the disease 
activity, the lower the levels of plasma thymulin. This data supports 
the concept of the involvement of the thymus gland in alopecia 
areata and complements the earlier findings of depressed thymic 
activity in those patients with more extensive hairloss. 
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V
ertical sections of small scalp biopsy specimens are 
often inadequate for the diagnosis of alopecia areata. 
The quantitative analysis of follicular structures in 
horizontal (transverse) sections can provide more 
information [1,2]. 
Our objectives were to confirm the diagnostic advantages of 
horizontal over vertical sections, to establish mean follicular counts 
in alopecia areata, and relate them to disease severity, to determine 
whether follicular depletion can occur in alopecia areata, and to 
compare follicular counts in alopecia areata, control, and other 
types of alopecia patients, for diagnostic purposes. 
MATERIALS AND METHODS 
Paired 4-mm punch biopsy specimens were taken from 22 controls and 287 
patients with alopecia areata for horizontal and vertical sectioning. In the 
horizontal sections, hair bulbs, anagen, catagen, and telogen hairs, telogen 
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germinal units, and veUus (including all miniaturized) hairs were counted, as 
were follicular units and follicular stelae (streamers). 
RESULTS 
The 22 normal controls, mean age 43 years, comprised a ratio of 
1.4:1 male to female subjects. The average 4-mm punch contained 
40 hairs (35 terminal, five vellus for a ratio of 7:1), with 93.5% 
anagen to 6.5% telogen hairs, 13 follicular units, and 1-2 follicular 
stelae. The 287 patients with alopecia areata had a mean age of 33 
years, in the ratio of 1:1.8 male to female subjects. The average 
duration of alopecia areata was 5 years in all 287 patients, 2 years in 
the 125 patients with limited patch alopecia, 6 years in the 119 
patients with extensive patch alopecia, 5 years in 20 patients with 
alopecia totalis, and 7 years in 23 patients with alopecia universalis. 
Diagnostic features of alopecia areata included a peribulbar lym­
phocytic infiltrate, and significantly decreased terminal hairs, in­
creased follicular stelae, decreased anagen and increased telogen 
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